BUZZ - Broker View: C.H. Robinson spends $5.8 billion to acquire RXO, putting the "bigger is better" argument to the test
路透社2026/10/06 09:00October 6 - Freight forwarding company C.H. Robinson Worldwide (CHRW.O) announced on Monday that it will acquire the smaller rival transportation brokerage company RXO (RXO.N) for $5.8 billion, marking the largest deal in its history. The acquisition aims to expand its market coverage in North American trucking brokerage and strengthen its "last-mile" delivery capabilities. RXO shares dropped nearly 2.5% pre-market, while C.H. Robinson traded flat amid light volume. Among analysts, 18 rate RXO as "hold", while 24 give CHRW an average "buy" rating. No risk, no freight. JPMorgan sees the share price drop triggered by the deal as an opportunity for investors who can remain patient and withstand future claims and execution uncertainties. TD Cowen stated surprise at the deal, citing legal liability concerns, RXO’s debt levels, customer overlap, and the timing of the transaction amid ongoing legal challenges within the freight brokerage sector. Benchmark acknowledged that while the deal increases Robinson's exposure to freight brokerage risk, legal liability, and debt—potentially diluting shareholder equity—the market is overlooking the significant earnings and cost-saving opportunities it creates. Baird said the acquisition creates value through cost synergies, expands customer and carrier coverage, lessens the impact of any single legal claim, and strengthens Robinson’s market position as large shippers shift freight business away from smaller brokers. (For the convenience of non-native English speakers, Reuters provides automated translations of its reports in several languages. As automated translations may contain errors or lack the required context, Reuters does not guarantee their accuracy and offers them solely for readers’ convenience. Reuters assumes no responsibility for any damage or loss caused by the use of the automated translation feature.)
October 6 - ** Freight forwarding company C.H. Robinson Worldwide (CHRW.O) said on Monday that it will acquire smaller rival transportation brokerage RXO (RXO.N) for $5.8 billion (link), marking its largest deal to date. The acquisition aims to expand its market coverage in the North American truck brokerage business and strengthen its "last mile" delivery capabilities.
** RXO fell nearly 2.5% in premarket trading; C.H. Robinson was flat on light volume.
** 18 analysts rated RXO as "hold", while 24 analysts gave CHRW an average rating of "buy".
No freight without risk-taking.
** JPMorgan believes that the share price drop triggered by this deal presents an opportunity for investors who are patient and can handle future claims and execution uncertainties.
** TD Cowen said the deal was unexpected, noting concerns about legal liabilities, RXO’s debt levels, customer overlap, and the timing of the deal amid ongoing legal challenges in the freight brokerage industry.
** Benchmark said that although the deal increases Robinson’s exposure to risks in the freight brokerage business, legal liabilities, and debt burden—and may dilute shareholder equity—the market is overlooking the substantial profit and cost-saving opportunities it creates.
** Baird stated that the transaction creates value through cost synergies, broadens customer and carrier coverage, lessens the impact of individual legal claims, and consolidates Robinson's market position as large shippers shift freight away from smaller brokers.
(To assist non-English speakers, Reuters has automated the translation of its reports into several other languages. As automated translations may contain errors or lack necessary context, Reuters does not guarantee their accuracy and provides them for readers’ convenience. Reuters accepts no responsibility for any damages or losses arising from the use of automated translation features.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Spyre Therapeutics shares tumble due to $350 million stock offering
On October 6, Spyre Therapeutics (SYRE.O) shares fell 4.1% to $88.90 in pre-market trading after the company priced a $350 million follow-on offering. The biotechnology firm announced late Monday that it was issuing approximately 4.1 million shares at $85 per share, an 8.3% discount to its last closing price. The company plans to use the net proceeds to advance its programs in gastroenterology, rheumatology, and dermatology, as well as to move a new project—SPY072—into later-stage development for the chronic skin disease hidradenitis suppurativa, among other uses. Jefferies, TD Cowen, Leerink, and Stifel are acting as joint book-running managers for the offering. On September 30, Merck’s (MRK.N) tulisokibart achieved success in a dermatology clinical trial, after which SYRE shares climbed about 5%. Analysts noted that the trial data supports SYRE's experimental candidate targeting the same signaling pathway. Headquartered in Waltham, Massachusetts, SYRE had around 88.2 million shares outstanding prior to the offering. As of Monday’s close, the stock had risen 183% year-to-date. According to LSEG data, 16 of 17 analysts rate the stock a “strong buy” or “buy,” with one analyst rating it “hold.” The median price target is $123. (For the convenience of non-English speakers, Reuters provides automated translations of its reports. Automated translations may contain errors or lack necessary context; Reuters makes no guarantee regarding the accuracy of machine translations and provides them for readers’ convenience only. Reuters accepts no liability for any damage or loss resulting from the use of automated translation.)
BUZZ-AMD shares rise on plans to increase chip supply
October 6 — U.S. chipmaker Advanced Micro Devices (AMD.O) saw its shares rise 1.5% in pre-market trading, reaching $641.10. CEO Lisa Su stated that as AMD races to meet surging demand in the artificial intelligence sector, the company plans to significantly boost chip supply by 2027 (link). Su also noted that AMD is working closely with memory chip manufacturers to ensure sufficient supply; her remarks come ahead of her scheduled visit to South Korea later on Tuesday. At least two brokerage firms, including Citigroup, have raised their price targets for the stock, according to data compiled by LSEG. Out of 56 brokerages, 47 rate AMD as a “buy” or higher, and 9 rate it as “hold”; the median price target is $616, per LSEG data. As of yesterday’s close, the stock has gained over 100% year-to-date. (For the convenience of non-English speakers, Reuters provides automated translations of its reports into several other languages. As automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of these texts and provides them solely for readers’ convenience. Reuters accepts no liability for any damages or losses arising from the use of automated translations.)
New York securities industry targets profits of 90 billions USD! Goldman Sachs (GS.US) breaks quarterly records three times, Wall Street bonuses to hit all-time high
Profits of the New York securities industry are expected to surpass 90 billions USD, exceeding last year’s record of 65.1 billions USD, with bonuses potentially reaching all-time highs; underwriting income has increased by 68%, contributing 26.3 billions USD to state finances.
Citigroup (C.US) accelerates promotion pace to counter private equity headhunting
Citi (C.US) is shortening the time required for investment banking analysts to be promoted to associates in order to attract and retain top talent in a highly competitive job market.
Crypto prices
More
